Dixon Wendy L insider trades
Dixon Wendy L has filed 26 Form 4s with the SEC that we hold, for Black Diamond Therapeutics, Inc. (BDTX) (Director), Incyte Corp (INCY) (Director), Zevra Therapeutics, INC. (ZVRA) (Director) and Alkermes plc. (ALKS) (Director), among 7 companies in all. Across all of them we count 0 purchases worth $0 and 1 sale worth $441.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 20,000 shares of Incyte Corp worth $441.0K, dated 2021-12-23. The first filing on our record is dated 2021-07-02 and the latest 2025-05-30.
Black Diamond Therapeutics, Inc. (BDTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Incyte Corp (INCY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-23 | S, sale reported on Form 4 | 20,000 | $441.0K | 2021-12-27 |
Zevra Therapeutics, INC. (ZVRA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Alkermes plc. (ALKS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Arvinas, INC. (ARVN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
BLUE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Iovance Biotherapeutics, INC. (IOVA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1202283) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms